|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Clovis Oncology, Inc. (CLVS) |
|
|
$0.02 0.00 (0.00%) as of 4:30 Mon 7/10
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
88,200,000 |
| Market
Cap: |
1.32(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.0103 - $0.042 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents. Co. markets Rubraca®, which is an oral small molecule inhibitor of poly ADP-ribose polymerase for indications specific to recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. Co.'s product candidates include: FAP-2286, a peptide-targeted radionuclide therapy and imaging agent targeting fibroblast activation protein; and Lucitanib, an oral potent angiogenesis inhibitor which inhibits vascular endothelial growth factor receptors 1 through 3, platelet-derived growth factor receptors alpha and beta and fibroblast growth factor receptors 1 through 3.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
79,699 |
| Total Sell Value |
$0 |
$0 |
$0 |
$104,765 |
| Total People Sold |
0 |
0 |
0 |
5 |
| Total Sell Transactions |
0 |
0 |
0 |
32 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Harding Thomas C. |
See Remarks |
• – – |
2022-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,896 |
19,260 |
|
- |
|
| Rolfe Lindsey |
See Remarks |
• – – |
2022-08-02 |
4 |
S |
$1.46 |
$6,326 |
D/D |
(4,330) |
107,060 |
|
92% |
|
| Gross Paul Edward |
See Remarks |
• – – |
2022-08-02 |
4 |
S |
$1.46 |
$7,024 |
D/D |
(4,807) |
90,057 |
|
92% |
|
| Ivers-Read Gillian C |
See Remarks |
• – – |
2022-08-02 |
4 |
S |
$1.46 |
$5,555 |
D/D |
(3,802) |
286,090 |
|
92% |
|
| Harding Thomas C. |
See Remarks |
• – – |
2022-08-02 |
4 |
S |
$1.46 |
$112 |
I/I |
(77) |
3,338 |
|
92% |
|
| Harding Thomas C. |
See Remarks |
• – – |
2022-08-02 |
4 |
S |
$1.46 |
$2,530 |
D/D |
(1,732) |
16,364 |
|
92% |
|
| Muehl Daniel W |
See Remarks |
• – – |
2022-08-02 |
4 |
S |
$1.46 |
$6,799 |
D/D |
(4,654) |
96,332 |
|
92% |
|
| Rolfe Lindsey |
See Remarks |
• – – |
2022-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,374 |
109,451 |
|
- |
|
| Gross Paul Edward |
See Remarks |
• – – |
2022-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,249 |
92,226 |
|
- |
|
| Ivers-Read Gillian C |
See Remarks |
• – – |
2022-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,374 |
288,190 |
|
- |
|
| Harding Thomas C. |
See Remarks |
• – – |
2022-08-01 |
4 |
OE |
$0.00 |
$0 |
I/I |
181 |
3,415 |
|
- |
|
| Harding Thomas C. |
See Remarks |
• – – |
2022-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,376 |
17,294 |
|
- |
|
| Muehl Daniel W |
See Remarks |
• – – |
2022-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,249 |
98,432 |
|
- |
|
| Harding Thomas C. |
See Remarks |
• – – |
2022-07-05 |
4 |
S |
$2.71 |
$19 |
I/I |
(7) |
3,234 |
|
88% |
|
| Harding Thomas C. |
See Remarks |
• – – |
2022-07-01 |
4 |
OE |
$0.00 |
$0 |
I/I |
16 |
3,241 |
|
- |
|
| Gross Paul Edward |
See Remarks |
• – – |
2022-06-02 |
4 |
S |
$0.64 |
$1,544 |
D/D |
(2,403) |
84,615 |
|
-64% |
|
| Rolfe Lindsey |
See Remarks |
• – – |
2022-06-02 |
4 |
S |
$0.64 |
$1,703 |
D/D |
(2,650) |
103,016 |
|
-64% |
|
| Muehl Daniel W |
See Remarks |
• – – |
2022-06-02 |
4 |
S |
$0.64 |
$1,495 |
D/D |
(2,327) |
90,737 |
|
-64% |
|
| Ivers-Read Gillian C |
See Remarks |
• – – |
2022-06-02 |
4 |
S |
$0.64 |
$1,495 |
D/D |
(2,327) |
281,518 |
|
-64% |
|
| Harding Thomas C. |
See Remarks |
• – – |
2022-06-02 |
4 |
S |
$0.64 |
$140 |
I/I |
(218) |
3,225 |
|
-64% |
|
| Harding Thomas C. |
See Remarks |
• – – |
2022-06-02 |
4 |
S |
$0.64 |
$966 |
D/D |
(1,504) |
14,720 |
|
-64% |
|
| Gross Paul Edward |
See Remarks |
• – – |
2022-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,062 |
87,018 |
|
- |
|
| Rolfe Lindsey |
See Remarks |
• – – |
2022-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,062 |
105,666 |
|
- |
|
| Muehl Daniel W |
See Remarks |
• – – |
2022-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,062 |
93,064 |
|
- |
|
| Ivers-Read Gillian C |
See Remarks |
• – – |
2022-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,062 |
283,845 |
|
- |
|
509 Records found
|
|
Page 2 of 21 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
